← back to search

Sanjoy Dutta

Borough of Manhattan Community College · US
Area of research
Surgery · Genetics
Research interest
Research interests include Pancreatic function and diabetes, Diabetes and associated disorders, Diabetes Management and Research, and Chemical Synthesis and Reactions.
h-index
24
citations
3,297
works
70
NIH funding
primary concept
Medicine
email

Recent publications

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology
The Lancet Diabetes & Endocrinology 2025cited by 9position: middledoi
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Diabetes Care 2024cited by 63position: middledoi
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
Diabetologia 2024cited by 55position: middledoi
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes
Diabetes 2024cited by 31position: middledoi
TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial
Frontiers in Immunology 2024cited by 18position: middledoi
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes
Diabetologia 2024cited by 3position: middledoi
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes
JAMA 2023cited by 161position: middledoi
Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes
JAMA 2023cited by 76position: middledoi
Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System
Ophthalmology Science 2023cited by 13position: middledoi
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
The Lancet Diabetes & Endocrinology 2022cited by 694position: middledoi
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
Diabetes Care 2019cited by 354position: middledoi
Glucose-responsive insulin by molecular and physical design
Nature Chemistry 2017cited by 152position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2024–2024) · 2 papers (2024–2024)Lee M. Jampol · Weatherford College1 papers (2023–2023)Helen M. Colhoun · Cleveland Clinic1 papers (2024–2024)Christine A. Curcio · Vanderbilt University1 papers (2023–2023)Thomas W. Gardner · University of Michigan1 papers (2023–2023) · 1 papers (2024–2024) · 1 papers (2023–2023)Thomas W. H. Kay · The University of Melbourne1 papers (2024–2024)Srinivas R. Sadda · University of California, Los Angeles1 papers (2023–2023)Zhen Gu · Sir Run Run Shaw Hospital1 papers (2017–2017)Elia J. Duh · Johns Hopkins University1 papers (2023–2023)Marc Y. Donath · University of Basel1 papers (2024–2024)Carla J. Greenbaum · Center for Infectious Disease Research1 papers (2024–2024)Colin Dayan · KU Leuven1 papers (2024–2024)Jay S. Skyler · University of Miami1 papers (2024–2024)Kevan C. Herold · Yale New Haven Hospital1 papers (2024–2024)N.A. Bakh · Massachusetts Institute of Technology1 papers (2017–2017)Tien‐En Tan · National University of Singapore1 papers (2023–2023)Courtney Ackeifi · Harvard Stem Cell Institute1 papers (2024–2024)